Uveitis: Clinical Trials

9 trials for Uveitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 unknown. 9 Phase 3, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 39Unknown 9
Phase 24Unknown 4

Follow Uveitis: new trials by email Literature Review of Uveitis trials Research Report on Uveitis

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Results of Suprachoroidal Steroids Injections in Two Chorioretinal Diseases
Triamcinolone Acetonide - Central Serous Chorioretinopathy, Irvine-Gass Syndrome
Phase 2 / Phase 3UnknownBenha University502022-04-142022-04-20
Efficacy, Safety and Costs of Methotrexate, Adalimumab, or Their Combination in Non-infectious Non-anterior Uveitis
Methotrexate, Adalimumab, Adalimumab+Methotrexate - Uveitis
Phase 3UnknownHospital San Carlos, Madrid1922022-01-122023-09-21
Beta-1,3/1,6-D-Glucan Ganoderma Lucidum on Non-infectious and Idiopathic Uveitis
Beta-1,3/1,6-D-Glucan Ganoderma lucidum, Placebos - Uveitis
Phase 2 / Phase 3UnknownFakultas Kedokteran Universitas Indonesia202020-01-212021-02-03
Multicenter, Randomized Study Evaluating the Value of Antitubercular Treatment During Recurent Anterior Uveitis (URBA)
Antitubercular treatment (RIFATER ©), Ethambutol, RIFINAH © - Uveitis, Anterior
Phase 3UnknownAssistance Publique - Hôpitaux de Paris1162019-11-012019-10-07
Use of Simvastatin as a Steroid Sparing Agent for Uveitis Patients
Simvastatin, Placebo - Uveitis
Phase 2 / Phase 3UnknownUniversity College, London502015-09-012017-10-26
Adalimumab in Uveitis Refractory to Conventional Therapy (ADUR Trial)
Adalimumab - Uveitis
Phase 2 / Phase 3UnknownHeidelberg University402006-08-012012-12-03
To Compare Intravitreal Clindamycin & Dexamethasone With Classic Treatment of Toxoplasmic Retinochoroiditis
pyrimethamine-sulfadiazine + prednisolone, Clindamycin+Dexamethasone - Chorioretinitis
Phase 3UnknownShahid Beheshti University of Medical Sciences2005-07-012008-07-30
Collaborative Ocular Melanoma Study (COMS)
Brachytherapy, Eye Removal - Choroid Neoplasms, Uveitis
Phase 3UnknownNational Eye Institute (NEI)1986-11-012006-06-02
The Safety and Efficacy of a Tumor Necrosis Factor Receptor Fusion Protein on Uveitis Associated With Juvenile Rheumatoid Arthritis
TNFR:Fc - Uveitis, Arthritis, Juvenile Rheumatoid
Phase 3UnknownNational Eye Institute (NEI)2005-06-24

Narrower conditions

Arthritis, Juvenile (1)  ·  Central Serous Chorioretinopathy (1)  ·  Chorioretinitis (1)  ·  Choroid Neoplasms (1)  ·  Macular Edema (1)  ·  Pars Planitis (1)  ·  Toxoplasmosis (1)  ·  Uveal Melanoma (1)  ·  Uveitis, Anterior (1)

Broader conditions

Eye Diseases (9)  ·  Uveal Diseases (9)  ·  Choroid Diseases (3)  ·  Panuveitis (3)  ·  Choroiditis (2)  ·  Retinal Diseases (2)  ·  Uveitis, Posterior (2)  ·  Arthritis (1)  ·  Autoimmune Diseases (1)  ·  Coccidiosis (1)  ·  Connective Tissue Diseases (1)  ·  Eye Neoplasms (1)  ·  Immune System Diseases (1)  ·  Infections (1)

Interventions

Adalimumab (2)  ·  Brachytherapy (1)  ·  Etanercept (1)  ·  Ethambutol (1)  ·  Eye Enucleation (1)  ·  Methotrexate (1)  ·  Prednisolone (1)  ·  Simvastatin (1)  ·  Triamcinolone Acetonide (1)  ·  isoniazid, pyrazinamide, rifampin drug combination (1)

Sponsors

National Eye Institute (NEI) (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Benha University (1)  ·  Fakultas Kedokteran Universitas Indonesia (1)  ·  Heidelberg University (1)  ·  Hospital San Carlos, Madrid (1)  ·  Shahid Beheshti University of Medical Sciences (1)  ·  University College, London (1)

Countries

Egypt (1)  ·  Germany (1)  ·  Indonesia (1)  ·  Iran (1)  ·  Spain (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Ahmed A Abdelshafy, MD (1)  ·  Hannes M Lorenz, MD (1)  ·  Luis Rodriguez Rodriguez (1)  ·  Lukman Edwar, SpM(K), Dr (1)  ·  Masoud Soheilian, MD (1)  ·  Matthias D Becker, MD (1)  ·  Oren Tomkins-Netzer, MD, PhD (1)  ·  Regina Max, MD (1)  ·  Sue Lightman, PhD,FRCOphth (1)

Results publications

PMID 17159027, PMID 17337065, PMID 17620582, PMID 19118701, PMID 35318229

NIH funding

2014 (1)